Sm14

BIOLOGICAL2 trials

Sponsors

Oswaldo Cruz Foundation

Conditions

Schistosomiasis

Phase 2

Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions

CompletedNCT03041766

Oswaldo Cruz FoundationSchistosomiasis

Start: 2016-12-06End: 2017-06-02Updated: 2017-12-14

Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children

CompletedNCT03799510

Oswaldo Cruz FoundationSchistosomiasis

Start: 2018-12-13End: 2019-08-07Updated: 2019-12-09

Related Papers

Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns

Journal of Clinical Investigation2025-04-031 citations